A Case of Intranasal Ketamine Misuse: Considerations for Clinical Practice

被引：3

作者：

Rivas-Grajales, Ana M. ^{[1
,2
]}

Mathew, Sanjay J. ^{[1
,2
]}

Rodgers, Joshua J. ^{[1
,3
]}

机构：

[1] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA

[2] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA

[3] Meninger Clin, Houston, TX USA

来源：

JOURNAL OF PSYCHIATRIC PRACTICE | 2021年 / 27卷 / 06期

关键词：

ketamine; depression; chronic pain; abuse potential; monitoring; DEPRESSION; ANTAGONIST;

D O I：

10.1097/PRA.0000000000000589

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Despite the growing off-label use of ketamine for depression and other psychiatric indications, its long-term safety profile and abuse potential remain unclear. We present a case of a patient who presented with paranoia and personality changes attributed to ketamine misuse, which illustrates the need for more robust screening and systematic monitoring with this medication. Continued evaluation of the abuse potential of ketamine in long-term treatment as well as restricted access and in-office administration are important, to develop a better understanding of the risk-benefit profile of this drug.

引用

页码：492 / 495

页数：4

共 21 条

[1]

Clark P, 2014, ANN CLIN PSYCHIATRY, V26, P145

[2] Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) [J].

Fava, Maurizio ;

Freeman, Marlene P. ;

Flynn, Martina ;

Judge, Heidi ;

Hoeppner, Bettina B. ;

Cusin, Cristina ;

Ionescu, Dawn F. ;

Mathew, Sanjay J. ;

Chang, Lee C. ;

Iosifescu, Dan V. ;

Murrough, James ;

Debattista, Charles ;

Schatzberg, Alan F. ;

Trivedi, Madhukar H. ;

Jha, Manish K. ;

Sanacora, Gerard ;

Wilkinson, Samuel T. ;

Papakostas, George I. .

MOLECULAR PSYCHIATRY, 2020, 25 (07) :1592-1603

[3] Psychiatric comorbidity of migraine [J].

Hamelsky, Sandra W. ;

Lipton, Richard B. .

HEADACHE, 2006, 46 (09) :1327-1333

[4]

Jansen K, 2000, DRUGLINK, V15, P18

[5] SUBANESTHETIC EFFECTS OF THE NONCOMPETITIVE NMDA ANTAGONIST, KETAMINE, IN HUMANS - PSYCHOTOMIMETIC, PERCEPTUAL, COGNITIVE, AND NEUROENDOCRINE RESPONSES [J].

KRYSTAL, JH ;

KARPER, LP ;

SEIBYL, JP ;

FREEMAN, GK ;

DELANEY, R ;

BREMNER, JD ;

HENINGER, GR ;

BOWERS, MB ;

CHARNEY, DS .

ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) :199-214

[6] NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers [J].

Malhotra, AK ;

Pinals, DA ;

Weingartner, H ;

Sirocco, K ;

Missar, CD ;

Pickar, D ;

Breier, A .

NEUROPSYCHOPHARMACOLOGY, 1996, 14 (05) :301-307

[7]

MORETON JE, 1977, J PHARMACOL EXP THER, V203, P303

[8] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial [J].

Murrough, James W. ;

Losifescu, Dan V. ;

Chang, Lee C. ;

Al Jurdi, Rayan K. ;

Green, Charles E. ;

Perez, Andrew M. ;

Lqbal, Syed ;

Pillemer, Sarah ;

Foulkes, Alexandra ;

Shah, Asim ;

Charney, Dennis S. ;

Mathew, Sanjay J. .

AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (10) :1134-1142

[9] Ketamine for chronic pain: risks and benefits [J].

Niesters, Marieke ;

Martini, Christian ;

Dahan, Albert .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (02) :357-367

[10] Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: A report of 3 cases [J].

Noppers, Ingeborg M. ;

Niesters, Marieke ;

Aarts, Leon P. H. J. ;

Bauer, Martin C. R. ;

Drewes, Asbjorn M. ;

Dahan, Albert ;

Sarton, Elise Y. .

PAIN, 2011, 152 (09) :2173-2178

← 1 2 3 →